| Gene Name: |
TNFSF8 |
| Species Reactivity: |
Human (Homo sapiens) |
| Synonyms: |
CD153 |
| Uniprot: |
P32971 |
| Description: |
this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, Properly used, This is a highly purified antibody with strong binding affinity towards the antigen that it has been risen against |
| Storage and handling: |
Generally, Reconstituted lyophilised and antibodies in liquid form can be shipped and stored for short terms at +4 degrees Celsius, it is recomended for long term storage (up to one year) 25-50% glycerol or ethylene glycol to be added and the vial must be stored at -20°, C, Lyophilized antibodies can be shipped at ambient temperature and stored for short terms at +4 degrees Celsius and at -20 for long term storage |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of the antibodies unchanged |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp |
| Gene target: |
TNFSF8 |
| Short name: |
Anti- TNFSF8 |
| Species: |
Humans, Human |
| Alternative name: |
member 8, sapiens tumor necrosis factor (ligand) superfamily, antibody to-H |
| Alternative to gene target: |
BT, CD153 and CD30L and CD30LG, Extracellular, TNFSF8 and IDBG-82328 and ENSG00000106952 and 944, Tnfsf8 and IDBG-155788 and ENSMUSG00000028362 and 21949, alpha-beta T cell differentiation and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0050830 and defense response to Gram-positive bacterium and biological process, member 8, protein binding, this GO :0005102 and receptor binding and molecular function this GO :0005125 and cytokine activity and molecular function this GO :0005164 and tumor necrosis factor receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005615 and extracellular space and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006915 and apoptotic process and biological process this GO :0006955 and immune response and biological process this GO :0007165 and signal transduction and biological process this GO :0007267 and cell-cell signaling and biological process this GO :0008283 and cell proliferation and biological process this GO :0016020 and membrane and cellular component this GO :0043374 and CD8-positive, this GO :0005102 : receptor binding, this GO :0005102 : receptor binding and also this GO :0005125 : cytokine activity and also this GO :0005164 : tumor necrosis factor receptor binding and also this GO :0005515 : protein binding, this GO :0005125 : cytokine activity, this GO :0005164 : tumor necrosis factor receptor binding, this GO :0005515 : protein binding, 44261 and IDBG-638653 and ENSBTAG00000025782 and 574056, tumor necrosis factor (ligand) superfamily |
| Identity: |
11938 |
| Gene: |
TNFSF8 |
More about : TNFSF8 |
| Long gene name: |
tumor necrosis factor superfamily member 8 |
| Synonyms gene: |
CD30LG |
| Synonyms gene name: |
member 8 , tumor necrosis factor (ligand) superfamily |
| Locus: |
9q32-q33, 1 |
| Discovery year: |
1993-11-08 |
| GenBank acession: |
L09753 |
| Entrez gene record: |
944 |
| Pubmed identfication: |
8391931 9349718 |
| Classification: |
Tumor necrosis factor superfamily CD molecules |
| Havana BLAST/BLAT: |
OTTHUMG00000021025 |